logo-loader
viewEmpower Clinics Inc.

Empower Clinics to sell Endocanna’s endocannabionoid DNA test kits at its healthcare facilities

Empower Clinics Inc (CSE:CBDT) CEO Steven McAuley tells Proactive Investors the Vancouver-based company has formed a strategic partnership with biotechnology company Endocanna Health. McAuley says Empower will sell California-based Endocanna's endocannabinioid DNA test kits through its health and wellness clinics in the U.S.
 

 

Quick facts: Empower Clinics Inc.

Price: 0.06 CAD

CSE:CBDT
Market: CSE
Market Cap: $8.04 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Empower Clinics Inc. named herein, including the promotion by the Company of Empower Clinics Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Empower Clinics sees another big increase in patients...

Empower Clinics (CSE: CBDT) Chairman and CEO Steven McAuley dropped into the Vancouver office of Proactive to tell Steve Darling about their record numbers for patient visits in September.  McAuley also told Proactive about a host of new services being offered within the clinics to...

5 days, 3 hours ago

2 min read